Minerva Neurosciences (NERV) Non-Current Deffered Revenue (2017 - 2020)

Minerva Neurosciences has reported Non-Current Deffered Revenue for 4 years, with the latest figure at $41.2 million in Q1 2020.

• For the quarter ending Q1 2020, Non-Current Deffered Revenue changed 0.0% year-over-year to $41.2 million; the trailing twelve-month figure through Mar 2020 stood at $41.2 million (changed 0.0% YoY), and the FY2019 full-year result was $41.2 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue for Q1 2020 stood at $41.2 million, roughly flat from $41.2 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $41.2 million in Q3 2017, with the low at $41.2 million in Q3 2017.
• Historically, Non-Current Deffered Revenue has averaged $41.2 million across 4 years, with a median of $41.2 million in 2017.
• The largest YoY upside for Non-Current Deffered Revenue was 0.0% in 2018 against a maximum downside of 0.0% in 2018.
• Minerva Neurosciences' Non-Current Deffered Revenue stood at $41.2 million in 2017, then changed by 0.0% to $41.2 million in 2018, then changed by 0.0% to $41.2 million in 2019, then changed by 0.0% to $41.2 million in 2020.
• The last three Non-Current Deffered Revenue figures came in at $41.2 million (Q1 2020), $41.2 million (Q4 2019), and $41.2 million (Q3 2019), per Business Quant data.